GCCL, LabConnect Sign MOU to Link APAC and North American Trial Labs
Image
Seoul – October 12, 2026 -- South Korea's GCCL and LabConnect signed a memorandum of understanding on October 12 to link their North American and Asia-Pacific (APAC) central laboratory capabilities for joint sales and project execution in global clinical trials.
Partners formalize a relationship spanning more than 20 years
The agreement builds on a collaboration that has run for more than 20 years. It aims to improve the operational efficiency of global trial projects by combining each company's regional expertise. Financial terms were not disclosed.
The signing took place at GCCL's headquarters. GCCL CEO Kwan-goo Cho attended, as did LabConnect's Jeff Mayhew, Founder and Strategic Commercial Advisor, and Joshua Gentile, Senior Vice President, Head of Commercial Sales and Marketing.